Esperion to Participate in Upcoming June Investor Conferences
Esperion to Participate in Upcoming June Investor Conferences
ANN ARBOR, Mich., May 23, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will be participating in the following webcasted investor events during the month of May, which can be found on our investor relations website.
密歇根州安娜堡，2024年5月23日（GLOBE NEWSWIRE）——埃斯佩里昂（納斯達克股票代碼：ESPR）今天宣佈，該公司將在5月份參加以下網絡直播的投資者活動，這些活動可在我們的投資者關係網站上找到。
Jefferies Global Healthcare Conference in New York on June 5, 2024, at 4:30 p.m. ET.
傑富瑞全球醫療保健會議將於美國東部時間2024年6月5日下午 4:30 在紐約舉行。
Goldman Sachs Healthcare Conference in Miami Beach on June 12, 2024, at 8:40 a.m. ET.
高盛醫療保健會議將於美國東部時間2024年6月12日上午8點40分在邁阿密海灘舉行。
Live webcasts can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company's website for approximately 90 days.
可以在Esperion網站的投資者和媒體欄目上觀看網絡直播。電話會議結束大約兩小時後即可訪問網絡直播重播，並將在公司網站上存檔約90天。
Esperion Therapeutics
At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life's work. For more information, visit esperion.com and esperionscience.com and follow us on X at twitter.com/EsperionInc.
Esperion Therapeu
在Esperion，我們發現、開發和商業化創新藥物，以幫助改善患有心血管和心臟代謝疾病或有患心血管和心臟代謝疾病風險的患者的預後。現狀無法滿足數百萬高膽固醇患者的健康需求——這就是爲什麼我們充滿激情的行業領導者團隊正在突破阻礙患者實現目標的障礙。提供者正在努力盡快將低密度脂蛋白膽固醇水平降至儘可能低；我們提供了下一步措施來幫助患者實現這一目標。因爲在高膽固醇方面，達到目標不是可選的。這是我們一生的工作。欲了解更多信息，請訪問 esperion.com 和 esperionscience 然後在 X 上關注我們 twitter.com/esperionin。
Esperion Contact Information:
Investors:
investorrelations@esperion.com
Esperion 聯繫信息：
投資者：
investorrelations@esperion.com
Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438
媒體：
蒂芙尼·奧爾德里奇
corporateteam@esperion.com
(616) 443-8438
譯文內容由第三人軟體翻譯。